FDA seizes contaminated heparin
Accreditation Connection, November 7, 2008
The US Food and Drug Administration (FDA) seized 11 lots of contaminated heparin from a Cincinnati, OH, laboratory this month.
US Marshalls seized two types of heparin from Celsus Laboratories, Inc., after discovering the products had been contaminated with over-sulfated chondroitin sulfate, a substance that mimics heparin’s anticoagulant activity.
To view the official FDA report, click here.
Comments
0 comments on “FDA seizes contaminated heparin ”
Related Products
-
Briefings on The Joint Commission
Briefings on The Joint Commission will help you with all of your accreditation and survey preparation needs. Every month...
-
The Joint Commission Mock Tracer Made Simple
This updated edition of our annual best-seller includes new tools and case studies of successful tracers from facilities...
-
Staffing Effectiveness Data:
You've spent an enormous amount of time, money, and effort collecting staffing effectiveness data - and you can still put it...
-
Complete Guide to Lab Safety, 3rd Ed.
The third edition of this popular resource makes training and compliance easier by consolidating regulations from all...
-
Simplifying Nursing Documentation
Implement a "two-form" solution that will cut nursing documentation in half while fully complying with Joint Commission...
Most Popular
- Articles
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- HIPAA Q&A: TPO disclosures to a business associate
- Q/A: Coding infusions to correct low potassium levels
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- The debate continues: Nurses who reported physician to the Texas Medical Board file federal appeal
- State medical board will hear unprofessional charges against OB-GYN
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- OB services: Coding inside and outside of the package
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Coding infusions to correct low potassium levels
- Know criteria for coverage when podiatrists use Dermagraft® tissue substitute
- Note: Clarification of reference (non-patient) laboratory testing
- Get the facts on coding for non-biodegradeable drug delivery implants
- Facility E/M Levels, 2009 OPPS
- Do not separately report defibrillation
- Defining 'integral' for self-administered drugs is challenging
- Consider the big picture before querying physicians
- Conference Update: 2012 CDI Professional of the Year nominations, poster session submission period open; additional discount hotel rooms acquired
- Searched